Back to Search
MARGARET FISCHL, MD
MD
Allergy & Immunology (Internal Medicine) Physician
NPI: 1801850326Individual
Specialties, Licenses & Credentials
Allergy & Immunology (Internal Medicine) PhysicianPrimary
Internal Medicine — Allergy & Immunology
Code: 207RA0201X
ME30600(FL)
Research & Publications (20)
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.
PMID 18373851·AIDS Res Ther·2008
8-other
Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen.
PMID 17255739·AIDS·2007
4-observational
Twice-daily Trizivir versus Combivir-abacavir in antiretroviral-experienced adults with human immunodeficiency virus-1 infection: a formulation-switch trial.
PMID 14620390·Pharmacotherapy·2003
3-trial
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.
PMID 12934177·J Infect Dis·2003
3-trial
Clinical trials within the Florida Department of Corrections.
PMID 11190127·Med Health R I·2000
8-other
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.
PMID 19380868·Blood·2009
3-trial
Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults.
PMID 18771406·J Infect Dis·2008
4-observational
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.
PMID 18677028·JAMA·2008
6-review
Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
PMID 17391891·J Pharm Biomed Anal·2007
8-other
Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).
PMID 17527093·J Acquir Immune Defic Syndr·2007
2-rct
Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
PMID 17926654·Antivir Ther·2007
8-other
Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: a descriptive study.
PMID 17711380·AIDS Patient Care STDS·2007
8-other
Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring.
PMID 17898644·Ther Drug Monit·2007
4-observational
Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV.
PMID 17324111·Pharmacogenomics·2007
4-observational
Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application.
PMID 17304157·Ther Drug Monit·2007
4-observational
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).
PMID 17109338·J Infect Dis·2006
3-trial
Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial.
PMID 16394845·J Acquir Immune Defic Syndr·2006
3-trial
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.
PMID 16905788·JAMA·2006
6-review
Evaluating an impression cytology grading system (IC score) in patients with dry eye syndrome.
PMID 16096658·Eye (Lond)·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1611 NW 12TH AVE, BOX 016960 M851
MIAMI, FL 33136 - Phone
- (305) 243-6484
Quick Facts
- NPI
- 1801850326
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile